Tous Actualités
Suivre
Abonner SYGNIS AG

SYGNIS AG

EANS-Adhoc: Dr. Alfred Bach resigns as CEO of SYGNIS Pharma AG

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
C.E.O. Interviews
28.10.2010
Ad-hoc
Dr. Alfred Bach resigns as CEO of SYGNIS Pharma AG
Heidelberg, 28 October 2010 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN 
DE0005043509; Prime Standard) announced today that the management 
contract of Dr. Alfred Bach, which is going to expire at the end of 
the calendar-year, will not be extended upon Dr. Bach´s request. By 
mutual consent with the Supervisory Board Dr. Bach will resign as CEO
of SYGNIS Pharma AG on the end of 28 October 2010.
The Supervisory Board thanks Dr. Bach for his commitment and efforts 
during the past years for SYGNIS Pharma AG. Peter Willinger, Chief 
Financial Officer, and, Dr. Frank Rathgeb, Chief Medical Officer, 
will jointly lead the Company.
For further information please contact:
|Dr. Franz-Werner Haas                   |
|VP Operations / General Counsel         |
|Tel: +49 (0) 6221-454 812               |
|Email:  franz-werner.haas@sygnis.de      |
end of announcement                               euro adhoc

Further inquiry note:

Dr. Franz-Werner Haas
VP Operations / General Counsel
Tel: +49 (0) 6221-454 812
Email: franz-werner.haas@sygnis.de

Branche: Biotechnology
ISIN: DE0005043509
WKN: 504350
Index: CDAX, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade

Plus de actualités: SYGNIS AG
Plus de actualités: SYGNIS AG
  • 12.08.2010 – 08:31

    EANS-News: SYGNIS announces three months results of fiscal year 2010/2011

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 3-month report Heidelberg (euro adhoc) - Press release Heidelberg, August 12, 2010 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today reports financial results for the first quarter of the fiscal ...

  • 29.06.2010 – 08:37

    EANS-News: SYGNIS announces Financial Results for fiscal year 2009/2010

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. annual report Heidelberg (euro adhoc) - Heidelberg, 29 June 2010 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today announced its financial results for the 2009/2010 fiscal year, which ended on 31 March ...